Enter at least 3 values to generate your report
Standard reference ranges are designed to detect disease — not to optimize healthspan. Enter your values and see exactly where you stand against the longevity-optimal ranges derived from peer-reviewed aging research.
Most standard annual bloodwork panels are designed to detect disease, not to optimize longevity. A longevity-focused panel is different in scope, in the reference ranges used for interpretation, and in how frequently certain markers should be tracked.
The following biomarkers should be tested at least annually for any adult over 35 interested in proactive longevity medicine. These are either widely available through standard lab orders or easily accessible through direct-to-consumer lab services.
ApoB (not just LDL-C — ApoB directly counts atherogenic particles), hsCRP (target below 0.5 mg/L, not the clinical "normal" of below 3.0), Lp(a) (test once — it's genetically determined and tells you if you have a lifetime elevated cardiovascular risk that requires aggressive ApoB management), triglycerides (longevity target below 80 mg/dL, not the clinical below 150), HDL-C and ApoA1. The ApoB:ApoA1 ratio is one of the strongest cardiovascular predictors available.
Fasting insulin (the most underused but revealing metabolic marker — optimal below 7 uIU/mL, not the clinical "normal" of below 25), HOMA-IR (calculated from fasting glucose and insulin), HbA1c (longevity target below 5.3%, not below 5.7%), fasting glucose (70–85 mg/dL optimal), ALT and GGT (hepatic function markers with tighter longevity-optimal ranges than standard labs use), eGFR (kidney function — decline rate is as informative as absolute value). Also consider uric acid, which has emerging evidence as an independent cardiovascular risk factor above 5.5 mg/dL.
TSH with Free T3 and Free T4 (TSH in the optimal 1.0–2.5 mIU/L range; request free hormones not just TSH), 25-OH Vitamin D (target 40–60 ng/mL, not the clinical "sufficient" of 20 ng/mL), Vitamin B12 (above 400 pg/mL, not the clinical cutoff of 200), homocysteine (sensitive marker for B12, folate, B6 status and independent vascular risk factor), RBC magnesium (serum magnesium is unreliable — RBC magnesium is the accurate measure of cellular status), and for men over 35: total testosterone with SHBG and calculated free testosterone.
Not all longevity biomarkers come from blood. VO₂max (the single strongest longevity predictor — test via graded exercise test or validated field test like the 12-minute Cooper test), grip strength (dynamometry — the Lancet PURE study found it predicted cardiovascular mortality better than blood pressure in 140,000 people), and resting heart rate (below 60 bpm reflects strong cardiovascular efficiency). HRV (heart rate variability) via a wearable adds daily trend data that lab tests cannot provide.
Once the Tier 1 panel is established as a baseline, the following tests add meaningful depth for adults serious about longevity optimization. They are more expensive and less universally available, but provide information not obtainable through standard panels.
CAC Score (Coronary Artery Calcium): A CT scan of the coronary arteries that directly measures calcified atherosclerotic plaque — the actual disease, not risk factors for it. A CAC of zero in someone over 40 is extremely reassuring even with other risk factors. A CAC above 300 requires aggressive intervention. This should be done once at age 40–45 and repeated if non-zero. Cost: approximately $100–200 out-of-pocket, not typically covered by insurance for preventive use.
DEXA Scan (Body Composition): Provides accurate lean mass, fat mass, bone density, and visceral fat area. BMI is nearly useless for longevity purposes — DEXA gives you the actual numbers that predict health outcomes. Low muscle mass index (Srikanthan et al., AJMED 2014) independently predicts mortality. High visceral fat area drives metabolic dysfunction even in people with normal BMI. Cost: $50–150; worth doing annually once you have a baseline.
Omega-3 Index: Measures EPA and DHA as a percentage of total fatty acids in red blood cell membranes — a 3-month average of omega-3 status. Below 4% is associated with high cardiovascular risk. Above 8% is the longevity target. Unlike blood plasma omega-3 tests, the RBC index is not acutely affected by recent fish consumption. Available through companies like OmegaQuant for approximately $60.
Epigenetic Age Testing: Tests like GrimAge (TruMe), GlycanAge, and the Levine PhenoAge bloodwork panel provide a direct estimate of biological age using DNA methylation patterns or protein glycosylation. These are the gold standard for biological age measurement — far more accurate than any questionnaire-based tool, including our own Biological Age Calculator. They are expensive ($300–500) but provide a baseline that is worth establishing in your 40s and tracking every 2–3 years. GrimAge specifically has the strongest longitudinal evidence for predicting mortality and healthspan decline.
Standard clinical reference ranges are set to identify pathology in a population sample — typically the middle 95% of measured values. They are designed to flag disease, not to identify the values associated with maximal healthspan and longevity. Being "within normal range" and being "optimized for longevity" are two completely different things.
Longevity medicine uses a different standard: what values are associated with the lowest all-cause mortality, slowest biological aging, and lowest long-term disease risk in large prospective studies? These optimal ranges are often substantially tighter than clinical reference ranges. Below are four examples of the gap:
Medical disclaimer: This tool provides educational interpretation of lab values based on published longevity research. It does not constitute medical advice, cannot account for individual health context, and should never replace consultation with a qualified physician. Lab results that fall into the "Needs Attention" category (outside standard range) should be discussed with your doctor promptly.
What to test, when, what to ask for — and how to interpret the results. Free monthly.